Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study

Autor: Yvette, Zimmerman, Mark, Frydenberg, Hendrik, van Poppel, R Jeroen A, van Moorselaar, Erik P M, Roos, Diederik M, Somford, Ton A, Roeleveld, Tjard D, de Haan, Harm H E, van Melick, Yacov, Reisman, Jan, Krijgh, Frans M J, Debruyne, Herjan J T, Coelingh Bennink

Publikováno v: European Urology Open Science, 45, 59-67. Elsevier BV
Zimmerman, Y, Frydenberg, M, van Poppel, H, van Moorselaar, R J A, Roos, E P M, Somford, D M, Roeleveld, T A, de Haan, T D, van Melick, H H E, Reisman, Y, Krijgh, J, Debruyne, F M J & Coelingh Bennink, H J T 2022, ' Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy : The PCombi Study ', European Urology Open Science, vol. 45, pp. 59-67 . https://doi.org/10.1016/j.euros.2022.09.006

BACKGROUND: Androgen deprivation therapy (ADT) for prostate cancer (PCa) is accompanied by side effects affecting health-related quality of life (HRQL). OBJECTIVE: To assess the effects of the fetal estrogen estetrol (E4) on symptoms related to estro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d41742ff006a0173ef57e6cc4c06df02
https://research.vumc.nl/en/publications/b9adeebb-3256-4593-a656-09a9a1caa278

Practical Aspects of Urinary Incontinence

Autor: Frans M. J. Debruyne, Ph.E.V.A. van Kerrebroeck

Urinary incontinence is becoming an increasingly dominant condition in daily urological and gynaecological practice, although the total number of patients suffering from the different forms ofincontinence remains unclear. An estimated figure for The

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2–3 N0 M0 prostatic carcinoma

Autor: Claude Schulman, Frans M. J. Debruyne, Wim P.J. Witjes

Publikováno v: Urology. 49:65-69

Objectives To evaluate the short- and long-term effects of neoadjuvant hormonal treatment in locally confined prostate cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f3da65ddbb46fac8f774711bc81552d2
https://doi.org/10.1016/s0090-4295(97)00171-4

Gonadotropin-releasing hormone antagonist in the management of prostate cancer

Autor: Frans M J, Debruyne

Publikováno v: Reviews in urology. 6

Luteinizing hormone-releasing hormone (LHRH) agonist therapy to induce medical castration has become the most common form of hormonal therapy for advanced and metastatic prostate cancer. When treatment is started, LHRH agonists initially stimulate th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e9b2e7fc6b13772f89c5789bb9d43985
https://pubmed.ncbi.nlm.nih.gov/16985933

Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data

Autor: Vera, Vandoninck, Michael R, van Balken, Enrico, Finazzi Agrò, Filomena, Petta, Francesco, Micali, John P F A, Heesakkers, Frans M J, Debruyne, Lambertus A L M, Kiemeney, Bart L H, Bemelmans

Publikováno v: Neurourology and urodynamics. 22(3)

The aim of this study was to evaluate urodynamic changes after percutaneous tibial nerve stimulation (PTNS) for the treatment of complaints related to overactive bladder syndrome and to search for urodynamic-based predictive factors.Ninety consecutiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::32f6891ac13b9400cdc53ef9339fa077
https://pubmed.ncbi.nlm.nih.gov/12926433